Format

Send to

Choose Destination
Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30004-8. doi: 10.1016/j.cllc.2020.01.004. [Epub ahead of print]

Clinical Course of Hypertrophic Pulmonary Osteoarthropathy in a Patient Receiving Immune Checkpoint Inhibitor Therapy.

Author information

1
Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: andrew.johns@osumc.edu.
2
Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH.
3
Division of Palliative Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
4
Division of Thoracic Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
5
Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
6
Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
7
Division of Rheumatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
8
Division of Sports Medicine, Department of Family Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.

KEYWORDS:

Hydroxychloroquine; Hypertrophic pulmonary osteoarthropathy; Immune checkpoint inhibitors; Lung cancer; Pain

PMID:
32067849
DOI:
10.1016/j.cllc.2020.01.004

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center